Literature DB >> 26063922

Neural activity selects myosin IIB and VI with a specific time window in distinct dynamin isoform-mediated synaptic vesicle reuse pathways.

Michikata Hayashida1, Shota Tanifuji1, Huan Ma1, Noriko Murakami2, Sumiko Mochida3.   

Abstract

Presynaptic nerve terminals must maintain stable neurotransmissions via synaptic vesicle (SV) resupply despite encountering wide fluctuations in the number and frequency of incoming action potentials (APs). However, the molecular mechanism linking variation in neural activity to SV resupply is unknown. Myosins II and VI are actin-based cytoskeletal motors that drive dendritic actin dynamics and membrane transport, respectively, at brain synapses. Here we combined genetic knockdown or molecular dysfunction and direct physiological measurement of fast synaptic transmission from paired rat superior cervical ganglion neurons in culture to show that myosins IIB and VI work individually in SV reuse pathways, having distinct dependency and time constants with physiological AP frequency. Myosin VI resupplied the readily releasable pool (RRP) with slow kinetics independently of firing rates but acted quickly within 50 ms after AP. Under high-frequency AP firing, myosin IIB resupplied the RRP with fast kinetics in a slower time window of 200 ms. Knockdown of both myosin and dynamin isoforms by mixed siRNA microinjection revealed that myosin IIB-mediated SV resupply follows amphiphysin/dynamin-1-mediated endocytosis, while myosin VI-mediated SV resupply follows dynamin-3-mediated endocytosis. Collectively, our findings show how distinct myosin isoforms work as vesicle motors in appropriate SV reuse pathways associated with specific firing patterns.
Copyright © 2015 the authors 0270-6474/15/358901-13$15.00/0.

Entities:  

Keywords:  action potential; dynamin; endocytosis; myosin; synaptic vesicle

Mesh:

Substances:

Year:  2015        PMID: 26063922      PMCID: PMC6605209          DOI: 10.1523/JNEUROSCI.5028-14.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  9 in total

1.  Myosin accelerates synaptic vesicle recycling in the motor nerve endings.

Authors:  P N Grigoryev; A L Zefirov
Journal:  Dokl Biol Sci       Date:  2016-11-08

2.  Synthesis and Evaluation of 4-Hydroxycoumarin Imines as Inhibitors of Class II Myosins.

Authors:  Jhonnathan Brawley; Emily Etter; Dante Heredia; Amarawan Intasiri; Kyle Nennecker; Joshua Smith; Brandon M Welcome; Richard K Brizendine; Thomas W Gould; Thomas W Bell; Christine Cremo
Journal:  J Med Chem       Date:  2020-09-18       Impact factor: 7.446

Review 3.  Millisecond Ca2+ dynamics activate multiple protein cascades for synaptic vesicle control.

Authors:  Sumiko Mochida
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

4.  The Calcineurin-Binding, Activity-Dependent Splice Variant Dynamin1xb Is Highly Enriched in Synapses in Various Regions of the Central Nervous System.

Authors:  Marie-Lisa Eich; Ekta Dembla; Silke Wahl; Mayur Dembla; Karin Schwarz; Frank Schmitz
Journal:  Front Mol Neurosci       Date:  2017-07-25       Impact factor: 5.639

5.  Myosin V functions as a vesicle tether at the plasma membrane to control neurotransmitter release in central synapses.

Authors:  Dario Maschi; Michael W Gramlich; Vitaly A Klyachko
Journal:  Elife       Date:  2018-10-15       Impact factor: 8.140

6.  Septin Polymerization Slows Synaptic Vesicle Recycling in Motor Nerve Endings.

Authors:  P N Grigoryev; G A Khisamieva; A L Zefirov
Journal:  Acta Naturae       Date:  2019 Apr-Jun       Impact factor: 1.845

Review 7.  Neurotransmitter Release Site Replenishment and Presynaptic Plasticity.

Authors:  Sumiko Mochida
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

Review 8.  Mechanisms of Synaptic Vesicle Exo- and Endocytosis.

Authors:  Sumiko Mochida
Journal:  Biomedicines       Date:  2022-07-04

9.  ERICH3: vesicular association and antidepressant treatment response.

Authors:  Duan Liu; Yongxian Zhuang; Lingxin Zhang; Huanyao Gao; Drew Neavin; Tania Carrillo-Roa; Yani Wang; Jia Yu; Sisi Qin; Daniel C Kim; Erica Liu; Thanh Thanh Le Nguyen; Joanna M Biernacka; Rima Kaddurah-Daouk; Boadie W Dunlop; W Edward Craighead; Helen S Mayberg; Elisabeth B Binder; Mark A Frye; Liewei Wang; Richard M Weinshilboum
Journal:  Mol Psychiatry       Date:  2020-11-23       Impact factor: 13.437

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.